Suppr超能文献

相似文献

1
A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma.
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12461-6. doi: 10.1073/pnas.1018941108. Epub 2011 Jul 11.
2
ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agents.
Clin Cancer Res. 2011 Sep 15;17(18):5973-81. doi: 10.1158/1078-0432.CCR-11-0955. Epub 2011 Aug 5.
5
Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol.
Clin Cancer Res. 2012 Sep 1;18(17):4600-11. doi: 10.1158/1078-0432.CCR-12-0839. Epub 2012 Jul 12.
6
Mantle cell lymphoma in cyclin D1 transgenic mice with Bim-deficient B cells.
Blood. 2014 Feb 6;123(6):884-93. doi: 10.1182/blood-2013-04-499079. Epub 2013 Dec 18.
8
The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies.
Blood. 2008 Oct 1;112(7):2906-16. doi: 10.1182/blood-2007-12-130781. Epub 2008 Jun 30.
10
Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications.
Mol Cancer Ther. 2010 Jul;9(7):2026-36. doi: 10.1158/1535-7163.MCT-10-0238. Epub 2010 Jul 6.

引用本文的文献

2
BH3 Mimetics in Hematologic Malignancies.
Int J Mol Sci. 2021 Sep 21;22(18):10157. doi: 10.3390/ijms221810157.
3
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance.
Cell Death Dis. 2020 Nov 2;11(11):941. doi: 10.1038/s41419-020-03144-y.
4
Molecular Pathogenesis of Mantle Cell Lymphoma.
Hematol Oncol Clin North Am. 2020 Oct;34(5):795-807. doi: 10.1016/j.hoc.2020.05.002. Epub 2020 Jul 22.
5
Iron chelation and 2-oxoglutarate-dependent dioxygenase inhibition suppress mantle cell lymphoma's cyclin D1.
J Cell Mol Med. 2019 Nov;23(11):7785-7795. doi: 10.1111/jcmm.14655. Epub 2019 Sep 13.
6
Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma.
Hum Pathol. 2019 Nov;93:54-64. doi: 10.1016/j.humpath.2019.08.008. Epub 2019 Aug 16.
7
Lipid nanoparticle siRNA cocktails for the treatment of mantle cell lymphoma.
Bioeng Transl Med. 2018 Apr 6;3(2):138-147. doi: 10.1002/btm2.10088. eCollection 2018 May.
8
Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms.
Haematologica. 2018 Jun;103(6):1065-1072. doi: 10.3324/haematol.2017.175687. Epub 2017 Nov 30.
10
Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.
Curr Oncol Rep. 2017 Jun;19(6):43. doi: 10.1007/s11912-017-0598-1.

本文引用的文献

1
Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.
Blood. 2010 Oct 7;116(14):2531-42. doi: 10.1182/blood-2010-02-268003. Epub 2010 Jun 22.
2
Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen.
Nature. 2010 Jan 21;463(7279):374-8. doi: 10.1038/nature08684.
3
Cell cycle kinases as therapeutic targets for cancer.
Nat Rev Drug Discov. 2009 Jul;8(7):547-66. doi: 10.1038/nrd2907.
4
How I treat mantle cell lymphoma.
Blood. 2009 Aug 20;114(8):1469-76. doi: 10.1182/blood-2009-02-179739. Epub 2009 Jun 25.
5
Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved?
Curr Opin Oncol. 2008 Sep;20(5):487-94. doi: 10.1097/CCO.0b013e32830b61c2.
6
Cyclin D1 in low-dose radiation-induced adaptive resistance.
Oncogene. 2008 Dec 4;27(53):6738-48. doi: 10.1038/onc.2008.265. Epub 2008 Aug 11.
9
Mantle cell lymphoma: identifying novel molecular targets in growth and survival pathways.
Hematology Am Soc Hematol Educ Program. 2007:270-6. doi: 10.1182/asheducation-2007.1.270.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验